Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
971.9000 5.80 (0.60%)
NSE Aug 21, 2025 13:17 PM
Volume: 18,754
 

logo
Alivus Life Sciences Ltd.
16 Jul 2024
971.90
0.60%
buy
by Hem Securities
Target: 987
Hem Securities
 
Alivus Life Sciences.. has an average target of 1317.00 from 1 broker.
More from Alivus Life Sciences Ltd.
Recommended
You must have heard about the panic around "falling birth rates". Maybe we need to calm down
The Baseline | 21 Aug 2025, 03:32PM
Market trades higher, Fortis Healthcare signs a pact to operate and manage a 550-bed hospital
Trendlyne Marketwatch | 21 Aug 2025, 01:17PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021